Cancer immunotherapy in progress-an overview of the past 130 years

Since the first approval of an immune-checkpoint inhibitor, we have witnessed the clinical success of cancer immunotherapy. Adoptive T-cell therapy with chimeric antigen-receptor T (CAR-T) cells has shown remarkable efficacy in hematological malignancies. Concurrently with these successes, the cance...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International immunology 2025-01
1. Verfasser:	Ikeda, Hiroaki
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!